Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
Steuber, H., Heine, A., Podjarny, A., Klebe, G.(2008) J Mol Biol 379: 991-1016
- PubMed: 18495158 
- DOI: 10.1016/j.jmb.2008.03.063
- Primary Citation of Related Structures:  
2PD5, 2PD9, 2PDB, 2PDC, 2PDF, 2PDG, 2PDH, 2PDI, 2PDJ, 2PDK, 2PDL, 2PDM, 2PDN, 2PDP, 2PDQ, 2PDU, 2PDW, 2PDX, 2PDY - PubMed Abstract: 
Inhibition of human aldose reductase (ALR2) evolved as a promising therapeutic concept to prevent late complications of diabetes. As well as appropriate affinity and bioavailability, putative inhibitors should possess a high level of selectivity for ALR2 over the related aldehyde reductase (ALR1) ...